Key result
PHILIA Phase SC-9a protocol outlines computational analysis of 182 substrates to test device-integrity replication.
Pre-registration protocol for PHILIA Phase SC-9a confirmatory analysis testing device-integrity replication and MSE→z slope differences in synthetic data.
Pre-registration of SC-9a confirmatory analysis bolsters transparency; leaves open whether hypotheses will be confirmed after 910 runs.
This document constitutes the pre-registration protocol for PHILIA Phase SC-9a, the confirmatory analysis stage of the SC-9a pipeline. SC-9a applies the locked v32 self-raw × 3-channel normalization apparatus to the 182-substrate integrated registry (SHA256: 3948b55114a6bad44296fa78cb6d53f8fc89d553137d3e6c0d683023344f7c9a) using five independent seeds [72–76], totaling 910 runs (182 substrates × 5 seeds × T=80,000 steps). Two confirmatory hypotheses are pre-registered under Bonferroni correction (α_family=0.05, k=2, α_per_test=0.025). H-SC9a-Primary is a device-integrity replication control: AR sub-family (n=19, AC1<0.95), Spearman ρ(θ_rank, ρ_at_θ) ≤ −0.90, exact permutation p<0.025, 6 θ-levels {0.10, 0.30, 0.50, 0.70, 0.80, 0.95}. Type I error P(ρ≤−0.90|H₀, n=6) = 0.0083 ✅. No escape clause. H-SC9a-Secondary tests whether the MSE→z slope differs between AR and Chaos Synthetic sub-families via OLS interaction model (z ~ MSE + AC1 + C(sub_class) + MSE×C(sub_class), AR+Chaos N=40). Verdict: interaction p<0.025 (single criterion; partial η² reported as effect size standard — conjoint redundancy disclosed). Pre-declared power: 0.42 (analytical) / 0.32 (Monte Carlo) at η²=0.10 — SC-8 L-8 continuity. Pre-registration lineage: SC-8 Results Report (10.5281/zenodo.20621215) → SC-9a Pre-registration (this document). SC-9b (Financial ARFIMA + LIGO H1/L1) maintained as separate track. Gate-0 v10 Cycle 9: UNCONDITIONAL ACCEPT (크리스 / Claude Opus / Anthropic).Power analysis SHA256: 35002523431384739d135f60b666364485c450c0325a5814cbd53f9d6a588a39 Trinity AI Research Team | Konyang University | 2026.06.11Measurement is life. Description, not proof. Pre-registration protects us. — PHILIA OS | 0∞1∞0.5∞
No takes yet. Share an insight, caveat, or question.
신두섭 (2026) studied this question. PHILIA Phase SC-9a pipeline was evaluated on Spearman ρ(θ_rank, ρ_at_θ) ≤ −0.90. The PHILIA Phase SC-9a pre-registration protocol outlines a computational analysis of 182 substrates to test device-integrity replication and MSE to z slope differences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: